Usage of Tramadol With Levobupivacaine for Pain Treatment After Cesarean Section
NCT ID: NCT01916915
Last Updated: 2016-06-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
PHASE4
65 participants
INTERVENTIONAL
2013-07-31
2016-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Analgesic Efficacy of Wound Infiltration With Tramadol
NCT02518438
Intrathecal Opioid Study
NCT02577809
The Impact of the SCN9A Gene Polymorphism on Postoperative Pain
NCT02496455
Intraperitoneal Tramadol Versus Dexmedetomedine for Analgesia After Abdominal Laparoscopic Cancer Surgeries
NCT04813016
Analgesia and Antihyperalgesia of Tramadol and Acetaminophen Per Oral After Caesarean Section
NCT00873743
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Tramadol 1
1 mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion
Tramadol infusion via wound catheter
Levobupivacaine
Tramadol 2
2mg/kg tramadol + 0.25% levobupivacaine 4 ml/h infusion
Tramadol infusion via wound catheter
Levobupivacaine
Levobupivacaine
0.25% levobupivacaine 4ml/h infusion
Levobupivacaine
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Tramadol infusion via wound catheter
Levobupivacaine
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* American Society of Anesthesiologists Class I-II
Exclusion Criteria
* Serious coagulopathy
* Serious systemic disease
* Story of allergy to drugs being used in the study
* Morbid obesity (Body mass index \> 30)
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ufuk University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Perihan Ekmekçi
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Perihan Ekmekçi, Associate Professor
Role: PRINCIPAL_INVESTIGATOR
Ufuk University Dr Rıdvan Ege Hospital Department of Anesthesiology and Reanimation
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Ufuk University Dr Rıdvan Ege Hospital
Ankara, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
09/06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.